Skip to main content

Capital Research Global Investors

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1422848 Los Angeles, CA

Position in BBIO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$56,712,510
-$91,272,540 QoQ
Shares Held
763,702
-60.5% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Capital Research Global Investors holds $13,789,933,930 across 16 Biotechnology names. BBIO ranks #10 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BBIO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $56,712,510 763,702
2025-12-31 $147,985,050 1,934,698
2025-09-30 $100,406,564 1,933,126
2025-06-30 $172,214,707 3,988,298
2025-03-31 $161,352,087 4,667,402
2024-12-31 $96,773,937 3,526,747
2024-09-30 $66,560,281 2,614,308
2024-06-30 $56,032,113 2,212,085
2024-03-31 $68,397,668 2,212,085
2023-12-31 $44,411,440 1,100,110
2023-09-30 $29,009,900 1,100,110